FDA fast-tracks psychedelics. Are you ready? | Live AMA | Apr 29 | FDA shift explained | Save your seat

Join us for a live 60-minute Q&A. The conversation will feature expert perspectives from Chuck Raison, MD, and Andrew Penn, MS, PMHNP-BC, with practical insights for psychiatric and behavioral health professionals navigating this rapidly evolving space. As momentum builds around psychedelic research and regulation, this timely discussion will examine what recent developments may mean and how clinicians can think about these therapies today.